School of Public Health, Wenzhou Medical University, Wenzhou, Zhejiang, P.R. China.
Zhejiang Provincial Key Laboratory of Watershed Science and Health, Wenzhou Medical University, Wenzhou, Zhejiang, P.R. China.
Commun Biol. 2024 Aug 14;7(1):990. doi: 10.1038/s42003-024-06680-x.
While circulating metabolites and immune system have been increasingly linked to hypothyroidism risk, the causality underlying these associations remains largely uninterrogated. We used Mendelian randomization to identified putative causal traits for hypothyroidism via integrating omics data. Briefly, we utilized 1180 plasma metabolites and 731 immune cells traits as exposures to identify putatively causal traits for hypothyroidism in the discovery (40,926 cases) and replication cohorts (14,871 cases). By combining MR results from two large-scale cohorts, we ultimately identified 21 putatively causal traits, including five plasma metabolites and 16 immune cell traits. CD3 on CD28 CD4 T cell and 1-(1-enyl-palmitoyl)-2-oleoyl-GPE (p-16:0/18:1) demonstrated the most pronounced positive and negative associations with hypothyroidism risk, respectively. The odds ratio and 95% confidence interval were 1.09 (1.07, 1.12) and 0.81 (0.75, 0.87), respectively. No evidence of horizontal pleiotropy, heterogeneity among instrumental variables or reverse causation were found for these 21 significant associations. Our study elucidates key metabolites and immune cell traits associated with hypothyroidism. These findings provide new insights into the etiology and potential therapeutic targets for hypothyroidism.
虽然循环代谢物和免疫系统与甲状腺功能减退症风险的关联越来越密切,但这些关联的因果关系在很大程度上仍未得到探究。我们使用孟德尔随机化方法,通过整合组学数据来确定甲状腺功能减退症的潜在因果特征。简而言之,我们将 1180 种血浆代谢物和 731 种免疫细胞特征作为暴露因素,在发现队列(40926 例)和复制队列(14871 例)中确定甲状腺功能减退症的潜在因果特征。通过合并两个大规模队列的 MR 结果,我们最终确定了 21 个潜在的因果特征,包括五种血浆代谢物和 16 种免疫细胞特征。CD3 on CD28 CD4 T 细胞和 1-(1-烯基-棕榈酰基)-2-油酰基-GPE(p-16:0/18:1)分别与甲状腺功能减退症风险呈最显著的正相关和负相关。比值比和 95%置信区间分别为 1.09(1.07,1.12)和 0.81(0.75,0.87)。对于这 21 个显著关联,没有发现水平多效性、工具变量之间的异质性或反向因果关系的证据。我们的研究阐明了与甲状腺功能减退症相关的关键代谢物和免疫细胞特征。这些发现为甲状腺功能减退症的病因学和潜在治疗靶点提供了新的见解。